Priority Date: 13.04.06 (US 20060791847P)

RNAi-mediated inhibition of spleen tyrosine kinase-related inflammatory conditions

  • Application ID: EP13176714
  • Status: GRANT OF PATENT INTENDED

Applicant

Technology company logo small
Technology Company

Attorney

Employment test 201 - 500 employees
Company dna grunecker kinkeldey stockmair and schwanhausser
operating since 1924
Headquarter in Munich and 2 offices
active in Legal Services

Specialization

This EP application has the IPC combination A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE) and C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING). We found, that TransMIT GmbH, Kailuweit & Uhlemann, Sperling Fischer & Heyner, Zacco, Lederer Keller Patentanwälte Partnerschaft mbB and 184 others are specialized in this combination either. For a similar patent, they might be a good choice.

Timeline

  • 13.04.2006 - Priority Date (US 20060791847P)
  • 13.11.2013 - Publication A2 (EP2662446)
  • 02.04.2014 - Publication A3 (EP2662446)

IPC Classification